Sacubitrilat
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
Synonyms | LBQ657 |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
PDB ligand | |
Chemical and physical data | |
Formula | C22H25NO5 |
Molar mass | 383.44 g·mol−1 |
3D model (JSmol) | |
| |
|
Sacubitrilat (INN; or LBQ657) is the active metabolite of the antihypertensive drug sacubitril,[1] which is used in the treatment of heart failure.[2]
References
- ↑ Solomon, SD. "HFpEF in the Future: New Diagnostic Techniques and Treatments in the Pipeline". Boston. p. 48. Retrieved 2012-01-26.
- ↑ "FDA approves new drug to treat heart failure". Food and Drug Administration. 7 July 2015.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.